In this Product Explainer, Dermatologist Dr Ryan De Cruz, explains the role of calcipotriol and betamethasone dipropionate foam spray for the topical treatment of psoriasis vulgaris in adults (6 mins).
In this Product Explainer, Professor of Obstetrics & Gynaecology, William Ledger explains the role of vaginal micronised progesterone, including the indication, safety profile, clinical trial background and guidelines for use for the treatment and management of threatened miscarriage (5 mins).
In this Product Explainer, Public Health Physician and Infectious Diseases Epidemiologist Prof Paul Van Buynder explains the burden of pneumococcal disease in both children and adult population. He explains why PCV 15 has increased serotype coverage and why improved immunogenicity against serotype 3 is important both from a clinical and public health perspective (5 mins).
In this Product Explainer, Pharmacist Dr Jacinta Johnson explains the schedule 3 supply of triptans as Pharmacist Only Medicine, and presents several considerations when choosing the appropriate triptan for the acute management of migraine (6 mins).
In this Product Explainer, Infectious Disease Physician and Clinical Microbiologist A/Prof Paul Griffin explains the recombinant protein nanoparticle COVID-19 vaccine with a proprietary adjuvant, including the mechanism of action, efficacy, and tolerability; and provides an update on boosters, indications, and access
(8 mins).
In this Product Explainer, Paediatric Immunologist and Allergist Dr Brynn Wainstein provides an update on the management of anaphylaxis, including an overview of the guidelines, action plan and prescribing information for the EpiPen® adrenaline injector device (5 mins).
In this Product Explainer, Respiratory, Sleep & Allergy Physician Dr Gregory Katsoulotos explains the role of beclometasone dipropionate, formoterol and glycopyrronium pressurised inhalation solution for maintenance treatment in adult patients with uncontrolled asthma despite treatment with an ICS and a LABA with a history of exacerbations (5 mins).
The rate at which health professionals direct patients with intermittent Gastro-oesophageal Reflux Disease (GORD) to an alginate/antacid combination, how extensively do we review current medications, and how they are taken to ensure the symptoms may not be iatrogenic, and whether to start with a short 7-day course of proton pump inhibitors (PPIs) or just write a prescription.
In this Product Explainer, Endocrinologist A/Prof Samantha Hocking explains the role of Liraglutide 3mg in obesity management and patients who may benefit from it (5 mins).
In this Product Explainer, Respiratory Physician Dr Kwok Yan explains the role of fluticasone furoate, umeclidinium and vilanterol dry powder triple therapy inhaler for the maintenance treatment of asthma in adult patients who are not adequately controlled with an ICS+LABA (7 mins).
Psychologist; Director, UNSW Ageing Futures Institute; ARC Laureate Fellow; Senior Principal Research Scientist, NeuRA
Scientia Prof Kaarin Anstey translates the WHO's updated 2026 dementia risk-reduction guidelines changes into concrete actions for opportunistic risk assessment and targeted advice in everyday general practice.
Podcasts
Videos
Clinical Articles
